- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07939438
Postoperative Stenting After Flexible Ureteroscopy in Children With Upper Urinary Tract Stones
Evaluation of the Need for Post-Operative Stenting After Flexible Ureteroscopy Using a Navigable Suction Ureteral Access Sheath in School-Age Children With Medium Sized Upper Urinary Tract Stones
This study aims to evaluate whether postoperative double-J ureteral stent placement can be safely avoided in children undergoing flexible ureteroscopy using a flexible and navigable suction ureteral access sheath (FANS-UAS) for upper urinary tract stones.
The study will include 50 children aged 6-16 years with upper urinary tract stones measuring 1-2 cm who undergo flexible ureteroscopy at Ain Shams University Hospitals.
During the procedure, a suction-assisted ureteral access sheath will be used to facilitate stone fragmentation and removal. The decision to place a postoperative ureteral stent will be based on intraoperative findings and the surgeon's assessment.
The study will assess the need for postoperative stenting, stone clearance, postoperative pain, fever, and other procedure-related complications to determine whether flexible and navigable suction ureteral access sheath (FANS-UAS) can reduce unnecessary stent placement while maintaining procedural safety and effectiveness.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Abdelrhman M Elbarbary, MBBCh
- Phone Number: +2 0 10 23839948
- Email: abdomedo6300@gmail.com
Study Locations
-
-
Cairo Governorate
-
Cairo, Cairo Governorate, Egypt, 11511
- Ain Shams University Hospitals
-
Contact:
- Abdelrhman M Elbarbary, MBBCh
- Phone Number: +2 0 10 23839948
- Email: abdomedo6300@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients aged 6 to 16 years of either sex.
- Patients with upper urinary tract stones measuring 1-2 cm.
Exclusion Criteria:
- Patients with untreated or active urinary tract infection (UTI).
- Patients with urinary tract stricture or pelvi-ureteric junction obstruction (PUJO).
- Patients with renal stones located in a calyceal diverticulum.
- Patients with a solitary kidney.
- Patients unfit for anesthesia.
- Patients in whom insertion of the navigable suction ureteral access sheath is unsuccessful.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: FANS-UAS-Assisted Flexible Ureteroscopy
All participants will undergo retrograde intrarenal surgery (RIRS) using flexible ureteroscopy assisted by a flexible and navigable suction ureteral access sheath (FANS-UAS) for the treatment of upper urinary tract stones. Laser lithotripsy will be performed using a holmium:YAG laser, with suction-assisted evacuation of stone fragments. The decision to place a postoperative double-J ureteral stent will be based on intraoperative findings, including residual stones, ureteral wall injury, bleeding, operative time, and surgeon discretion. Participants will undergo postoperative follow-up for one month. |
A 9.5 Fr suction ureteral access sheath (ClearPetra) will be inserted into the ureter during retrograde intrarenal surgery (RIRS). The sheath tip will be positioned in the renal pelvis or calyces near the stone and connected to a suction device. Negative pressure will be adjusted intraoperatively to facilitate irrigation fluid drainage, maintain visualization, and evacuate stone fragments during holmium:YAG laser lithotripsy. The procedure will be performed using a 7.5 Fr flexible ureteroscope. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Successful Avoidance of Postoperative Double-J Ureteral Stenting
Time Frame: Up to 1 month after surgery
|
Proportion of patients in whom postoperative double-J ureteral stent placement is avoided following flexible ureteroscopy using FANS-UAS without requiring an additional postoperative intervention during follow-up. |
Up to 1 month after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Stone-Free Rate Following Flexible Ureteroscopy
Time Frame: Up to 1 month after surgery
|
Proportion of patients without residual stone fragments larger than 4 mm, assessed using kidney, ureter, and bladder (KUB) radiography and non-contrast computed tomography of the urinary tract (NCCTUT). |
Up to 1 month after surgery
|
|
Postoperative Pain Score
Time Frame: Up to 1 month after surgery
|
Postoperative pain severity assessed using a visual analogue scale (VAS) ranging from 1 to 10, with higher scores indicating greater pain intensity. |
Up to 1 month after surgery
|
|
Incidence of Postoperative Fever
Time Frame: Up to 1 month after surgery
|
Proportion of patients experiencing postoperative fever following FANS-UAS-assisted flexible ureteroscopy. |
Up to 1 month after surgery
|
|
Operative Time
Time Frame: During surgery
|
Duration of the surgical procedure, measured in minutes. |
During surgery
|
|
Incidence of Ureteric Stricture
Time Frame: Up to 1 month after surgery
|
Proportion of patients diagnosed with ureteric stricture during postoperative follow-up. |
Up to 1 month after surgery
|
|
Incidence of Calyceal Rupture
Time Frame: During surgery
|
Proportion of patients experiencing calyceal rupture during the surgical procedure. |
During surgery
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Urogenital Diseases
- Male Urogenital Diseases
- Calculi
- Pathological Conditions, Anatomical
- Kidney Diseases
- Urologic Diseases
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Urinary Calculi
- Ureteral Diseases
- Nephrolithiasis
- Pathological Conditions, Signs and Symptoms
- Ureterolithiasis
- Kidney Calculi
- Ureteral Calculi
- Urolithiasis
Other Study ID Numbers
- FMASU MS 610/2026
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.